angiotensin receptor antagonists

Preferred Label : angiotensin receptor antagonists;

MeSH definition : Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR.;

MeSH synonym : antagonists, angiotensin receptor; receptor antagonists, angiotensin; angiotensin receptor blockers; receptor blockers, angiotensin; Angiotensin Receptor Blocker; Blocker, Angiotensin Receptor; Receptor Blocker, Angiotensin; Angiotensin Receptor Antagonist; Antagonist, Angiotensin Receptor; Receptor Antagonist, Angiotensin;

MeSH hyponym : angiotensin II receptor antagonists; Angiotensin II Receptor Blockers; Angiotensin II Receptor Antagonist; Angiotensin II Receptor Blocker;

Wikipedia link : https://en.wikipedia.org/wiki/Angiotensin receptor blockers;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D057911;

UMLS CUI

C0815017;

ATC code(s)
- Angiotensin II receptor blockers (ARBs) and calcium channel blockers [ATC Code]
- Angiotensin II receptor blockers (ARBs) and diuretics [ATC Code]
- Angiotensin II receptor blockers (ARBs), combinations [ATC Code]
- Angiotensin II receptor blockers (ARBs), plain [ATC Code]
- Angiotensin II receptor blockers (ARBs), plain [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Braj Language [NCIt concept]
- Brazil [NCIt concept]
- angiotensin II receptor blocker [COVID-19 Thesaurus concept]
MeSH Descriptor(s) used for indexing
- receptors, angiotensin [MeSH Descriptor]
Record concept(s)
- angiotensin II receptor antagonists [MeSH concept]
- angiotensin receptor antagonists [MeSH concept]
See also (suggested by CISMeF)
- receptors, angiotensin [MeSH Descriptor]
See also inter- (CISMeF)
- Angiotensin II receptor antagonist (disposition) [SNOMED CT concept]
- Product containing angiotensin II receptor antagonist (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 2-(butyryl-(2'-(4,5-dimethylisoxazol-3-ylsulfamoyl)biphenyl-4-ylmethyl)amino)-N-isopropyl-3-methylbutyramide [MeSH Supplementary Concept]
- 2-(butyryl-(2'-(4-chloro-5-methylisoxazol-3-ylsulfamoyl)biphenyl-4-ylmethyl)amino)-N-isopropyl-3-methylbutyramide [MeSH Supplementary Concept]
- 2-(butyryl-(2'-(4-fluoro-5-methylisoxazol-3-ylsulfamoyl)biphenyl-4-ylmethyl)amino)-N-isopropyl-3-methylbutyramide [MeSH Supplementary Concept]
- 2-methylsulfanyl-3-(2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl)-3H-quinazolin-4-one [MeSH Supplementary Concept]
- L 158809 [MeSH Supplementary Concept]
- L 159913 [MeSH Supplementary Concept]
- L 163017 [MeSH Supplementary Concept]
- L 163082 [MeSH Supplementary Concept]
- L 163958 [MeSH Supplementary Concept]
- SL 910102-90 DL [MeSH Supplementary Concept]
- XR 510 [MeSH Supplementary Concept]
- dimethyl (1-methyl-1,3-benzimidazol-5-yl)aminomethylenepropanedioate [MeSH Supplementary Concept]
- sacubitril and valsartan sodium hydrate drug combination [MeSH Supplementary Concept]
Validated automatic mappings to BTNT
- Angiotensin II Receptor Antagonist [NCIt concept]
- Angiotensin II receptor blockers (ARBs), plain [ATC Code]
- Substance with angiotensin II receptor antagonist mechanism of action (substance) [SNOMED CT concept]
- angiotensin ii receptor antagonist, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients